Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Unknown status Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20153
20181
20192
20202
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Gynecologic Oncology Group2
Advenchen Laboratories, LLC1
Affiliated Cancer Hospital & Institute of Guangzhou Medical University1
Guangxi Medical University1
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1
Jiangsu HengRui Medicine Co., Ltd.1
Lee's Pharmaceutical Limited1
Shanghai Yunying Medical Technology1
Shenzhen SiBiono GeneTech Co.,Ltd1
Shu-Zhong Cui1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms12
Ovarian Neoplasms8
Carcinoma, Ovarian Epithelial7
Recurrence2
Adnexal Diseases1
Carcinoma1
Endocrine Gland Neoplasms1
Endocrine System Diseases1
Endometrial Neoplasms1
Genital Diseases, Female1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.